SAM
MDCO

Sandell Asset Management’s Medicines Co MDCO Stock Holding History

Sandell Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-234,037
Closed -$19.9M – 76
2019
Q4 		$19.9M Buy
+234,037
New +$15.6M 3.22% 11

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Sandell Asset Management's MDCO Position: Q1 2020 in Review

Sandell Asset Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 234,037 shares — an estimated $19.9M sold.

Sandell Asset Management first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $19.9M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Sandell Asset Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Sandell Asset Management sold 234,037 Medicines Co shares in Q1 2020, an estimated $19.9M.
  • Sandell Asset Management first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
  • Sandell Asset Management's Medicines Co position peaked at $19.9M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Sandell Asset Management's 13F filing for Q1 2020, filed 15 May 2020.